Singular Genomics sets IPO terms, to raise up to $187 million and be valued at up to $1.5 billion

Retrieved on: 2021-05-24 11:03:45

Tags for this article:

Click the tags to see associated articles and topics

Singular Genomics sets IPO terms, to raise up to $187 million and be valued at up to $1.5 billion. View article details on hiswai:

Excerpt

J.P. Morgan, Goldman Sachs, BofA Securities, Cowen and UBS are the underwriters. The company recorded a net loss of $27.9 million on no revenue ...

Article found on: www.marketwatch.com